ReviewFrontiers in endocrinology2023
Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor.
Douglas Tremblay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewFrontiers in endocrinology2023
Douglas Tremblay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.